Phase I studies of darinaparsin in patients with relapsed or refractory peripheral T-cell lymphoma: a pooled analysis of two phase I studies conducted in Japan and KoreaMichinori Ogura, Kensei Tobinai, Youko Suehiro et al.|Japanese Journal of Clinical Oncology|2020Cited by 15
Two Phase I and Pharmacokinetic Studies of Darinaparsin (Organic Arsenic Compound) in Japanese and Korean Patients with Relapsed or Refractory (R/R) Peripheral T-Cell Lymphoma (PTCL)Won-Seog Kim, Hirokazu Nagai, Michinori Ogura et al.|Blood|2015Cited by 1